Androgens have distinct physiological functions within the ovary. The biological action of androgens is primarily exerted through transcriptional regulation by the nuclear androgen receptor (AR), but the molecular cascades governed by AR remain largely unknown. At present, there is imminent concern that environmental man-made chemicals with antiandrogenic properties, among others, are capable of modulating hormonal responses, thereby interfering with normal physiological processes that are critical to fertility. In the present study, we aimed to further characterize a standardized and reproducible follicle culture system in terms of AR expression during in vitro folliculogenesis to be able to use it as a bioassay to study effects of antiandrogens on follicular and oocyte growth, steroid secretion profile, and oocyte meiotic maturation capacity. Immunohistochemical analysis revealed that cytoplasmic AR protein was translocated to the nucleus of granulosa and theca cells in response to endogenous androgen production in theca cells during preantral follicular development. During the antral phase in vitro, AR was differentially expressed in mural and cumulus cells, implying an oocyte-mediated regulation. Treatment of follicles with hydroxyflutamide or bicalutamide, two model antiandrogenic compounds, resulted in reduced follicular growth during the preantral phase, altered steroidogenic environment, and arrest in oocyte meiotic maturation in response to human chorionic gonadotropin. Androgen receptor expression in the culture model corresponded well to what is described in vivo, and this system revealed several ovarian functions targeted by AR antagonists that can be further investigated using more in-depth molecular techniques.
INTRODUCTION
Increasing numbers of industrial chemicals with hormonelike properties are being identified as endocrine disrupters (EDs) capable of altering male and female sexual functions and posing important environmental concern [1, 2] . Because the function of the reproductive system depends critically on hormone concentrations and their balance, disturbances caused by endocrine disruption may result in impaired fertility [3] . Although concerns about increased infertility and early menopause in women have been raised [4] , the exact lesions within the female reproductive system are generally more difficult to diagnose considering the complexity of regulation of the female reproductive system.
Female reproduction depends on a succession of multiple integrated processes in which the ovary has two important roles; it produces fertilizable gametes during a process of folliculogenesis, and it is an important site of steroid production that directly participates in folliculogenesis through endogenously expressed receptors and indirectly affects ovarian cyclicity through regulation of the neuroendocrine system. To investigate the underlying mechanistic actions of EDs on ovarian functions, biologically relevant in vitro test systems are urgently needed. Whereas receptor binding assays, cell proliferation assays, and receptor gene assays allow for rapid screening of the antiestrogenic and/or antiandrogenic properties of a given compound [5] [6] [7] , they are incapable of predicting the physiological effect of the concerned xenobiotics because they lack true biological significance. After all, a biological response is determined by the distinct cell-and tissue-specific expression patterns of proteins and their transcription cofactors. Animal or human primary (in this case, ovarian) cells in culture allow analysis of the normal regulation of endogenous hormone-sensitive genes that possess the required machinery (including cell-specific transcription cofactors with which the xenobiotics might interact) involved in gene expression. An important drawback is that most of these cell systems are complex and difficult to standardize. The follicle culture system described by Cortvrindt and Smitz [8] cultures early preantral follicles up to the preovulatory stage during 12 days, while maintaining the functionality of the cell types. This follicle culture is highly reproducible [8] and could serve as a biologically relevant bioassay because it allows analysis of folliculogenesis, oogenesis, and steroidogenesis during a longer period in response to compounds added to the culture medium. As opposed to models using granulosa or theca cells separately, follicle culture maintains part of the natural interrelationships between ovarian cell types that are important to normal folliculogenesis and oogenesis. Although the system has already been extensively standardized and characterized [8, 9] , no data exist on expression patterns of androgen receptor (AR), a likely target for endocrine disruption of female fertility.
Androgen receptor functions as a ligand-activated nuclear transcription factor that detects subnanomolar concentrations of cellular androgens and converts the androgen signal into changes in gene expression [10] . In addition to their transcriptional or genomic mode of action, androgens can exert rapid nongenomic effects [11, 12] , which may ultimately serve to modulate the transcriptional activity of AR or other transcription factors.
Studies [13] [14] [15] [16] [17] [18] in different species have documented the expression of Ar mRNA and AR protein in various ovarian cell types. Most reported granulosa cells as the predominant cellular site of AR expression. In primate and rodent, Ar mRNA and AR protein are developmentally regulated and were present in greatest amounts in ovaries containing immature preantral/early antral follicles and decreased throughout preovulatory follicular development [15] [16] [17] .
Testosterone and its metabolite 5a-dihydrotestosterone (DHT) are the two most potent naturally occurring agonists of the AR. Ligand-activated AR has been shown to modulate follicle-stimulating hormone (FSH) action in developing granulosa cells through amplification of cAMP-mediated postreceptor signaling [19] , serving as an important modulator of granulosa cell differentiation and follicular development. This androgenic action is of physiological significance during early antral stages of follicular development, which are particularly dependent on FSH. Granulosa cell responses to FSH during antral follicular development include changes in androgen metabolism due to altered expression of steroidogenic enzymes such as P450scc, P450arom, and 5a-reductase, providing a possible mechanism for regulating the relative type and amount of androgen that are present in the follicle. Folliclestimulating hormone-responsive genes also govern responsiveness to luteinizing hormone (LH) (e.g., LH receptor) and paracrine/autocrine signaling (e.g., inhibin/activin) [20] . By modulating FSH responsiveness at intermediate stages of follicular growth, androgens contribute to the mechanism that determines which follicles are selected to develop further and eventually achieve full preovulatory maturity. During preantral follicular development, androgens were shown to promote primary to secondary follicle transition [21] . The present study focused on characterizing the follicle culture system further in terms of AR expression during in vitro growth and evaluated the effects of antagonizing AR-mediated actions on follicular growth and development, steroid output, and oocyte growth and maturation by continuously exposing the follicles to two well-known specific but weak AR antagonists, hydroxyflutamide (OHF) and bicalutamide.
MATERIALS AND METHODS

Immunohistochemistry from In Vitro-Grown Follicles
Follicle culture. Female F1 hybrid (C57BL/6J 3 CBA/Ca) mice housed and bred according to national standards were used throughout the study. This study was approved by the institutional ethical committee for animal experiments of Vrije Universiteit Brussel (project 01-395-1).
Thirteen-day-old mice were killed by cervical dislocation, and the ovaries were aseptically removed and collected in 2-ml L15 Leibovitz-glutamax medium supplemented with 10% fetal bovine serum (FBS), 100 lg/ml of streptomycin, and 100 IU/ml of penicillin (L15* medium) (all obtained from Life Technologies, Merelbeke, Belgium). All steps were performed at 378C.
Under a normal stereomicroscope, the ovaries were freed from connective tissues and placed in 1 ml of fresh L15* medium. Follicles were mechanically released from the ovaries using fine 25½-gauge needles (Becton Dickinson, Erembodegem, Belgium). In two washing steps (L15* medium), follicles with the following characteristics were selected: 1) a diameter between 100 and 130 lm containing 2) an immature oocyte centrally located within the follicle, showing intact connections with surrounding granulosa cells, and 3) an intact basal membrane 4) surrounded by some theca cells. All selected follicles were pooled, and after a final washing step in culture medium, they were randomly divided over different culture plates.
Follicles were individually cultured for 13 days [8] in 96-well plates (12 follicles per plate) (Costar; Elscolab, Kruibeke, Belgium) in 75 ll of medium. We opted to modulate the endocrine environment of cultured follicles by subtracting or adding androgens from/to the culture medium to verify possible culture-related differences in AR expression.
As a control culture condition, a-minimal essential medium supplemented with 5% FBS, 10 mIU/ml of FSH, and 10 mIU/ml of LH (added once at the beginning of culture to stimulate theca cells) (ITS mix, 5 lg/ml, 5 lg/ml, 5 ng/ ml; Sigma-Aldrich, Bornem, Belgium) (standard culture medium) [22] was chosen and examined for AR expression. Starting from this condition, two other conditions were considered in which either 1) testosterone was added (5 nM) from the beginning of culture onward or 2) follicles were cultured under an oil overlay, thereby subtracting the lipophylic substances, including steroids, from the culture medium [8] . In the latter case, follicles were cultured in 5 3 20-ll droplets of standard culture medium on glass coverslips (24 3 24 mm) (to enable high-magnification confocal microscopic visualization), placed in small Petri dishes (35 3 10 mm), and covered with 3 ml of mineral oil (Sigma-Aldrich).
During culture, each follicle was individually evaluated and scored according to preset parameters such as follicle survival and follicular morphology [8] . Briefly, normally at Day 2, follicles are still follicular and are surrounded by the basal membrane, and some theca cells start to attach to the bottom of the dish. At Day 4, granulosa cells have started to proliferate through the basal membrane, which gives the follicle a ''diffuse'' appearance (for a detailed explanation, see Adriaens et al. [22] Double immunohistochemical labeling. Immunohistochemical procedures were performed within the culture wells or on the coverslips within culture dishes. Follicles were fixed in 2% paraformaldehyde for 30 min at room temperature at different representative time points of culture (Days 2, 4, 8, 12, and 13); follicles were stored in PBS at 48C or immediately stained. Cells were permeabilized with 0.2% Triton X-100 in PBS for 25 min and then blocked with 10% normal goat serum (NGS) in PBS for 15 min at room temperature. The cultured follicles were incubated overnight at 48C with the specific antibody diluted in PBS with 1% dimethyl sulfoxide (DMSO) and 1.5% NGS. Following extensive washing with PBS þ 0.02% Triton X-100 þ 1.5% NGS, follicles were incubated with secondary antibody in PBS with 1% DMSO and 1.5% NGS for 2 h at room temperature. After washing, follicles were incubated in Texas Red-phalloidine (T7471, 1:40; Invitrogen) for 1 h at room temperature to visualize cell contours. Finally, the follicles underwent a clearing procedure that consisted of successive washes through 50%, 70%, and 90% glycerol in PBS. As negative controls, a preadsorption control and the omission of the primary antibody were included.
Confocal microscopic analysis. Stained follicles were viewed, fixed in 96-well plates or to the culture coverslip, through an Olympus IX 70 Fluoview confocal laser scanning microscope system (Omnilabo, Leuvin, Belgium) equipped with an argon-krypton laser (488-568 nm) with band-pass filter (510-540 nm), and long-pass filter (610 nm) to visualize Alexa Fluor 448 and Texas Red-phalloidine, respectively, using 103 and 203 UPlanApo objectives (air). Follicles were scanned through different planes along the z-axis, at 10-lm distance in between, rendering about seven sections from follicular morphology.
An average of six follicles per condition and per time point was evaluated (one experiment, five time points). Each condition was repeated three times (i.e., an average of 18 follicles per time point).
OHF and Bicalutamide Exposure During Follicle Culture
Culture conditions. Unlike cultures destined for immunohistochemical proceedings, follicles undergoing OHF and bicalutamide treatment were cultured slightly differently. After isolation, they were first put in standard culture medium (75 ll) for 24 h to let them recover from mechanically induced stress. After that, they were transferred to the various conditions with OHF or bicalutamide, with 10 per plate chosen that strictly met the criteria of follicle diameter, connections, and presence of theca cells (as already described). The total number of days in culture was 13 days for all follicles (Fig. 1) . Seven conditions were studied per compound, and experiments were repeated three times (140 follicles recovered from four mice per repeat and per compound). A bioassay and solvent (DMSO) control was included in parallel with five doses of OHF (Chemical Abstracts Service Registry no.: 52806-53-8; Toronto Research Chemicals Inc., Toronto, ON) or bicalutamide (Casodex, Chemical Abstracts 686 LENIE AND SMITZ Service Registry no.: 90357-06-5; Alexis Biochemicals, Zandhoven, Belgium) over a concentration range of 5 nM to 50 lM. Stock solutions of OHF and bicalutamide were made in DMSO, and the final DMSO concentration in the medium was 0.02%. This solvent concentration has been tested previously and did not affect follicular development or survival, nor did it affect meiosis of cultured oocytes (our unpublished data). Osmolarity of the OHF-and bicalutamide-supplemented medium remained normal throughout the concentration ranges. Follicles were cultured for 13 days at 378C and 5% CO 2 in air at 100% humidity and were scored for follicular growth and development as described earlier. Surviving follicles were defined as follicles that maintained their oocyte interconnected with granulosa cells during the 13-day culture. At Day 12 of culture, an ovulatory stimulus was administered (1.2 IU/ml of hCG and 8 ng/ml of EGF); at 18 h thereafter, the first mucification was scored as good (well expanded) or bad (not expanded), and then the oocytes within the expanded cumulus-oocyte complexes (COCs) were stripped from their surrounding cumulus cells by gentle mouth-controlled pipetting to evaluate their nuclear maturation. They were measured and scored as 1) GV when the germinal vesicle was still visible, 2) GVBD when it was broken down, or 3) PB when the first polar body was extruded. In an additional experiment, 50 nM DHT (Sigma-Aldrich) was added to OHF or bicalutamide treatment.
AR protein expression during OHF exposure. Follicles cultured in the presence of 50 lM OHF were stained for AR protein at the different time points in culture (as described earlier). The effects of OHF on cellular and subcellular AR expression were evaluated.
Hormone assays. Estrogen concentrations increase during follicle development and differentiation. Progesterone (P 4 ) production remains low and rises modestly toward the end of the culture period [8] . Premature luteinization is defined as a premature rise in P 4 production along with a decrease in estrogen production.
During refreshment of the follicle culture (every 4 days), 30 ll of conditioned medium from the surviving follicles was collected and pooled per plate (10 follicles) and stored at À208C on hormone measurement. All immunoassays have been adapted for their use on conditioned medium. 17b-Estradiol (E 2 ) production was measured using a direct radioimmunoassay from clinical assays (Estradiol-2; Sorin Fueter, Brussels, Belgium) having a functional sensitivity of 20 ng/L and a total imprecision profile of less than 10% coefficient of variation (CV) for concentrations between 50 and 750 ng/L. Progesterone secretion was determined before and after the maturation stimulus using a direct radioimmunoassay (Cis Biointernational, Gif-sur-Yvette, France). This assay has a functional sensitivity of 0.5 lg/L and a total imprecision profile of less than 10% CV for concentrations between 3 and 50 lg/L. Testosterone was measured by direct radioimmunoassay (Orion Diagnostica, Espoo, Finland). The analytical sensitivity of this assay is 0.07 lg/L, and the total imprecision profile CV of less than 10% is observed for concentrations from 0.1 to 50 lg/L.
Inhibin B was measured by ELISA (Inhibin B kit; Oxford Bio Innovation, Oxfordshire, England) after dilution of conditioned medium. The sensitivity of the method was 15 ng/L, and the reproducibility was 12% or less CV. Because inhibin B production reflects granulosa cell mass [23, 24] , the proportional increase in inhibin B production between Days 8 and 12 was measured to quantify the relative growth of follicles in the different OHF doses, as it in fact signifies the number of times the granulosa cell mass had increased during the interval. Because 30 ll of medium (of 75 ll) per well was exchanged every 4 days, the proportional increase was calculated as the ratio of the concentration 
Statistical Analysis
For immunohistochemistry purposes, six follicles were evaluated per time point (one experiment, five time points) and per condition. Three conditions were tested, and each condition was repeated three times (90 follicles per condition). Unless stated otherwise, the figures are representatives of three independent experiments in standard culture conditions.
Percentage data were subjected to arc-sine transformation. Quantitative data of hormone analysis and oocyte meiotic maturation were analyzed by one-way ANOVA with Tukey posttest using GraphPad Prism (version 3.02; GraphPad Software, San Diego, California). The level of significance was set at 5%. Values are given as mean 6 SEM.
RESULTS
Immunohistochemical Analysis of AR Expression In Vitro
No differences in cellular AR localization were found between the various culture conditions tested. Overall, AR immunoreactivity was found in the oocyte, granulosa cells, and theca cells, but its subcellular localization differed. The preadsorption control was negative for all days examined.
AR expression in follicles in standard culture control conditions. After 2 days of culture, follicles were still compacted. Some cells had attached to the culture plate and were identified as theca cells in a previous study [9] . One fourth of the follicles examined at this early in vitro growth stage showed a weak and more diffused immunosignal within their granulosa cells ( Fig. 2A, left) , meaning that the signal appeared smeared, comprising nucleus and cytoplasm. Theca cells attached to the bottom of the culture well forming a monolayer ( Fig. 2A , left bottom) and those still adherent to the basal membrane ( Fig. 2A, encircled) showed overall cytoplasmic staining ( Fig. 2A, left bottom) . In the rest of the follicles, some granulosa cells started showing nuclear staining ( Fig. 2A , right) as in the theca cells. At this time, the oocyte demonstrated small and large spots within its cytoplasm. The large spots were mostly concentrated around the nucleus ( Fig.  2A, arrow, and Fig. 3 ).
After 4 days of culture, 95% of follicles examined displayed a clear and intense nuclear AR immunosignal in all granulosa and theca cells. The oocyte again featured small and large dots of AR immunoreactivity within its cytoplasm ( Fig. 2B and Fig.  3 ), but a more dense focal staining pattern was observed within the nucleus (excluding the nucleoli) (Fig. 3) .
After 8 days of culture, no notable changes in subcellular AR expression were observed compared with Day 4, but some early antral follicles demonstrated differentiated staining between granulosa cell types (i.e., cumulus and mural cells became apparent in terms of intensity, with cumulus cells showing more staining) (Fig. 2C, right) . This differentiated staining pattern between cumulus and mural cells became gradually more pronounced as follicles advanced to the preovulatory stage in vitro (Day 12) (Fig. 2D) .
Eighteen hours after administering the ovulatory stimulus (Day 13), we observed strong nuclear staining of cumulus cells in the mucified COC, but mural cells showed a much weaker signal (Fig. 2E, left) . This was also noted within the plated theca and granulosa cells (Fig. 2E, right) , where some immunoreactivity was translocated to perinuclear cytoplasmic regions (arrows). Distinction between both attached cell types was based on morphology as described in a previous study [9] . The oocyte still displayed sparse dots within its ooplasm.
AR expression in follicles in modified culture conditions. To determine whether the predominance of AR in the nucleus at a given growth stage in vitro is dependent on the presence of androgens produced and secreted within the culture medium, we evaluated two other conditions. Follicles cultured under oil still clearly showed cytoplasmic/diffused staining after 4 days of culture (Fig. 4B ), although they were at the same developmental stage as those cultured for 4 days in the absence of oil. The oocytes of follicles cultured under oil AR EXPRESSION DURING MOUSE FOLLICLE CULTURE exhibited strong speckling of AR immunoreactivity (Fig. 4B,  right) , which appeared slightly stronger compared with those cultured without oil (Fig. 3 ). Follicles supplemented with 5 nM testosterone from the beginning of culture (Day 0) displayed a completely translocated immunosignal to the nucleus after 24 h, whereas control follicles (no testosterone supplementation) still displayed cytoplasmic/diffused immunostaining (Fig. 4A,  left) .
Antagonizing AR Actions In Vitro: OHF and Bicalutamide AR expression in OHF-treated follicles. As demonstrated in Figure 5 , AR immunoreactivity in granulosa cells was partially translocated to the nuclei in the presence of 50 lM OHF (standard culture medium) after 24 h compared with completely diffused staining in control follicles. This means that apparently OHF can bind and translocate the AR to the nucleus. Some nuclei stained intensely (arrows), which was not seen in control follicles at this time (Day 1). Strikingly, similar to oocytes cultured under an oil overlay, highly speckled AR immunoreactivity was found within the cytoplasm and nucleus (nucleolus excluded) of the oocytes, which was no longer observed at Day 8 of culture. Thereafter, OHF-treated follicles showed a staining pattern comparable to that of control and testosterone-treated follicles.
The effects of long-term exposure of OHF were further evaluated. The most relevant parameters of the culture system were observed [8] .
Follicular development. Follicle survival was unaffected in OHF-treated or bicalutamide-treated follicles; all follicles retained their oocyte and responded to the hCG/EGF stimulus (data not shown). During preantral follicular development in ¼ 630 lm) . A) After 2 days of culture, diffused staining is observed within granulosa cells (GC) (on the left; to clarify the view, only the green staining is shown). The inset shows a higher magnification of the signal in GC. The TC display cytoplasmic staining. B) After 4 days of culture characterized by the outgrowth of GC through the basal membrane (asterisk), AR is located in the nuclei of GC. The TC also show nuclear staining. Some foci were found within the cytoplasm of the O. C and D) After Day 8 of culture, the outer mural compartment (MC) and the inner cumulus cells (CC) exhibit nuclear staining, as do the TC and the GC attached (AGC) to the culture plate (bottom). C) Some follicles show a differential staining pattern (right), with the inner CC staining more intensely. The asterisks represent the antral-like cavity formation within the follicle. D) After 12 days of culture, most of the follicles show more intensely stained nuclei of CC compared with the weaker signal in mural cells. E) In response to the ovulatory stimulus (Day 13), the immunosignal was decreased in mural cells but not in CC, which still exhibited an intensely stained nucleus. Some foci were also still apparent within the O. The TC and AGC showed decreased immunoreactivity that seemed to be shifted to cytoplasmic perinuclear regions (right, arrows). TZP, transzonal projections.
vitro, follicles exposed to the highest concentration of OHF and bicalutamide (50 lM) clearly showed reduced follicular growth because all follicles still exhibited a follicular-like phenotype after 4 days of culture (Fig. 6A) , in contrast to control follicles that all reached a diffused phenotype characterized by the outgrowth of granulosa cells through the basal membrane, considered to be the first hallmark of pronounced granulosa cell proliferation in the system (Fig. 6A, arrowhead) . Also, a clearly smaller follicular diameter could be morphologically observed after 8 days of culture compared with control follicles. Nevertheless, as follicular development progressed, the obviously affected follicles eventually reached a morphologically normal preovulatory stage by Day 12 in the presence of 50 lM OHF. In contrast, follicles exposed to 50 lM bicalutamide were not fully differentiated by Day 12 of culture but did develop an antral-like cavity. Lower concentrations of OHF or bicalutamide ( 5 lM) had no visible effects on follicle morphology or follicular development.
To quantify granulosa cell number in OHF-and bicalutamide-challenged follicles at Day 8 and Day 12, inhibin B production was measured and was significantly (P , 0.05) decreased in follicles treated with 50 lM OHF (Fig. 6B ) and 50 lM bicalutamide (Fig. 6D) , confirming morphological observations of reduced follicular growth. However, the proportional increase in inhibin B production between Day 8 and Day 12 was significantly augmented in the highest concentrations of both antagonists (Fig. 6 , C and E), confirming that follicles initially significantly smaller at Day 8 showed an increased growth rate during this interval, although they were not completely capable of reaching the same cellular volume as controls and those in lower antagonist concentrations (Fig. 6, B and D) .
Meiotic maturation. The ovulatory stimulus was given in the presence of different concentrations of OHF or bicalutamide. When exposed to a 50 lM concentration of either antagonist during their growth and maturation phase, oocytes were unable to resume meiosis because 80% 6 23% (P , 0.05) of the OHF-treated oocytes and 91% 6 4% (P , 0.05) of the bicalutamide-treated oocytes were arrested at the GV stage (Fig.  7, A and B, respectively) . Nevertheless, follicles had developed a normal preovulatory follicular phenotype, their COCs mucified equally well in response to the ovulatory stimulus (indicating normal follicular differentiation and LH responsiveness), and oocyte diameters had reached normal maximal size (data not shown). Furthermore, we found no higher incidence of oocyte release or oocyte degeneration during antagonist exposure (data not shown). No statistical difference was found in oocyte meiotic maturation when oocytes were exposed to a concentration range of OHF from 5 nM to 5 lM. Although not significant, there was a tendency to an inverted parabolic doseresponse relationship when follicles were cultured with 50 nM OHF showing less PB extrusion (59% 6 21%) as a result of a higher percentage of oocytes arrested at the GVBD stage (Fig.  7A) . In contrast, bicalutamide exposure resulted in a more gradual concentration-dependent decrease in PB extrusion.
Addition of 50 nM DHT did not overcome the meiotic arrest induced by OHF (Fig. 7C) , but it partially overcame the meiotic arrest induced by bicalutamide. A mean of 31% 6 13% of the oocytes in 50 lM-treated follicles were able to extrude their PB when DHT was added (Fig. 7C) .
Steroid output. Progesterone production was slightly elevated by Day 12 of culture in the highest concentration of OHF (50 lM) tested, while it was still normal after 8 days of culture (Fig. 8) . Although there was a slight concentrationdependent reduction in P 4 output at Day 13 of culture in response to hCG, suggestive of premature luteinization of OHF-treated follicles before the ovulatory stimulus, this was not statistically significant. During bicalutamide treatment, P 4 production was decreased in a concentration-dependent manner at Day 8 and Day 12 of culture and in response to the ovulatory stimulus (Fig. 8) . Testosterone production in the various concentrations of OHF was not significantly different from that of controls (data not shown) but was slightly decreased in the bicalutamide treatment condition, possibly reflecting decreased P 4 synthesis (data not shown). Estradiol production was decreased in a concentration-dependent manner in follicles exposed to OHF and reached significance (P , 0.05) at Day 8 of culture (in 50 lM OHF) and at Day 12 (in 50 lM and 5 lM OHF) (Fig. 8) . Also in bicalutamide-treated follicles, E 2 production tended to decrease compared with control follicles, whereas no E 2 was produced in the highest concentration (P , 0.05) (Fig. 8) . As revealed by inhibin B measurement, the significantly reduced granulosa cell mass of the 50 lMchallenged follicles may be a plausible cause. The E 2 :testosterone ratio was significantly reduced only in the highest concentration of both antagonists (Fig. 8 ) and shows that aromatase activity was unaffected at lower concentrations. However, the significantly lower E 2 production in the 5 lM condition cannot be ascribed to a reduced number of granulosa cells because inhibin B production appeared normal (Fig. 6B) . The testosterone:androstenedione ratio showed a concentration-dependent reduction for both antagonist treatments (P , 0.05 for 50 lM bicalutamide). 
LENIE AND SMITZ
DISCUSSION
This study demonstrates AR expression in mouse follicles cultured from the early preantral stage onward. It also characterizes the effects of antagonizing AR during in vitro folliculogenesis.
Preantral Follicular Development In Vitro
During preantral follicular development in vitro (Days 2-4 of culture), we observed a transition phase in subcellular AR localization. The weak and diffuse AR immunoreactivity within granulosa cells seen after 2 days of culture was completely translocated to the nucleus by 4 days of culture. Similar displacement of immunoreactivity was observed within theca cells. In the absence of ligand, the inactive AR predominantly resides within the cytoplasm [25, 26] , and on ligand binding inducing the release of receptor-associated proteins, the nuclear localization signals of the receptor are unmasked and recognized by the import apparatus of the nuclear pore complex [27, 28] . Furthermore, the AR is a highly mobile protein continuously shuttling between nucleus and cytoplasm in the presence of saturating concentrations of ligand [28] [29] [30] . Based on these findings, we hypothesized that the diffused immunostaining observed during the early growth phase corresponded to an intermediate translocation state of the AR, most likely due to the low androgen abundance at that time. After all, in vivo immunohistochemical findings show strong nuclear AR immunoreactivity in rodent granulosa cells from the primary follicle stage onward in the absence of androgen-secreting theca cells [15] , suggesting that there is sufficient environmental androgen (probably secreted from stromal cells) to drive AR into the nucleus. It is plausible that follicles removed from their natural environment quickly lose nuclear AR localization and maintain this feature until they are once again exposed to sufficient androgen in culture.
Similarly, in rat prostate a depletion of testicular androgens by castration caused ARs to redistribute from the nucleus to the cytoplasm [31] . Because culture starts off with only a smattering of theca cells surrounding the follicles, it is not illogical that this might take about 4 days of culture to complete. We brought proof of concept by adding testosterone (5 nM) to the culture medium, which resulted in immediate translocation (observed at 24 h) of AR immunoreactivity to the nucleus. Reversely, when androgen concentrations in the medium were decreased (by culturing under oil [8] ), follicles were delayed in reaching a predominantly nuclear signal and were still found in the transitory stage even after 4 days of culture. These findings validate that this mouse follicle culture model has apparently normal AR signaling characteristics, but we learn that without an exogenous androgen supplement follicles require approximately 4 days to build up a sufficient androgen pool to relocate AR to the nucleus. This is an important finding if the model is to be used to study the molecular aspects of AR signaling at the earliest stages of folliculogenesis or to examine EDs that may have their greatest effect at this period of growth.
During the early preantral phase, we noticed smaller and/or larger foci within the cytoplasm of the oocyte adjacent to the nucleus. In analogy, Gill et al. [32] described AR expression mainly in the cytoplasm of the oocyte and virtually absent in the nucleus. However, in the present study the oocyte nucleus increasingly stained over time, displaying a more dense focal staining pattern than the ooplasm, while nucleoli were found to be negative at least up to the late preantral stage (Day 4). In contrast, Szoltys et al. [33] reported gradual translocation of the AR from cytoplasm to the germinal vesicle (very weakly) and further to the nucleoli (very strongly) during late preantral and antral follicular development. Because we did not systematically scan oocytes at higher magnification, we cannot exclude possible immunostaining within nucleoli during antral follic- ular development. According to the literature, the fine foci observed within the oocyte nucleus could represent specific subnuclear compartments in which the receptor recruits coactivators before binding to promoters and enhancers of target genes (preassembly) [34] [35] [36] and might suggest a role for AR as a ligand-activated transcription factor in the oocyte [37] [38] [39] . The nature of the cytoplasmic foci remains to be further investigated. The number of cytoplasmic foci was increased in oocytes cultured under an oil overlay (lower androgen concentrations) and might reflect an inactive receptor associated with specific cytoplasmic structures.
Antral Follicular Development In Vitro
During antral follicular growth in vitro (Days 8-12), we observed differentiated intensity staining in between the outer mural compartment and the inner cumulus cells surrounding the oocyte, which became gradually more pronounced. These   FIG. 8 . Analysis of conditioned medium collected from surviving follicles. Graphs show the concentrations of P 4 and E 2 at different days and the testosterone:androstenedione ratio (Ratio T/A 4 ) and E 2 :testosterone ratio (Ratio E 2 /T) in the two treatments. Each bar in each graph represents the average of six plates (10 follicles per plate) from three repetitions, and those with differing letters were significantly (P , 0.05) different from each other. Conc, concentration.
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LENIE AND SMITZ findings are in accord with earlier reports on the developmental regulation of AR expression during FSH-induced follicular differentiation in the rat and primate ovary [15] [16] [17] and more recently in porcine granulosa cells [40] . In response to the ovulatory stimulus, cumulus cells of the extruded mucified COC still exhibited bright nuclear staining, in contrast to the luteinized mural and theca cells. This centripetal gradient of granulosa cell AR immunostaining strongly suggests that AR expression is under the control of oocyte-secreted factors [41, 42] and possibly defines differences in hormonal responses. This also implies that within the ovary AR expression may have an important role in local control mechanisms during follicular development. Because the changing spatial and temporal pattern of AR expression, the stage of follicle development, and possibly the androgen concentration during follicle growth may have important roles in regulating the extraovarian and intraovarian mechanisms ultimately determining follicular fate, this system could be a suitable physiologically relevant model to study each of these parameters.
Antagonizing AR Actions In Vitro
To study the effects of antagonizing AR-mediated actions on follicle growth, differentiation, oocyte maturation, and steroid output in vitro, two clinically used specific AR antagonists were used, OHF and bicalutamide. Both have a structure similar to that of testosterone and act by preventing the binding of testosterone and DHT to the AR. However, compared with the natural ligands testosterone and DHT, they possess significantly lower binding affinity (10 À3 ) to the receptor [43] and require high concentrations. Bicalutamide has an affinity two to four times higher than that of OHF [44] .
In analogy to other studies [38, [45] [46] [47] , antagonist-induced nuclear translocation of AR immunoreactivity was seen within the first day of culture in a definite number of somatic cells. These findings demonstrate that, at least during early in vitro preantral follicular development when androgen concentrations are still low, antagonists can exert their antiandrogenic actions. Large cytoplasmic dots were observed within the antagonisttreated oocyte that might represent an aggregation of receptor molecules, possibly imputed to changes in the conformation of antagonist-bound receptor. In analogy, cytoplasmic aggregates have been described in androgen insensitivity syndrome and in spinal and bulbar muscular atrophy [36, 48, 49] resulting from mutant AR forms with complete loss of ligand-dependent DNA-binding ability that manifests as delayed nuclear translocation.
Follicles that were chronically exposed to 50 lM of either antagonist showed severe delay in follicular growth up to Day 8 of culture (early antral growth phase), which was confirmed by significantly reduced production of inhibin B, a marker reflecting granulosa cell amounts [23, 24] . During preantral follicular development, locally produced androgens act via granulosa cell AR to promote FSH-induced granulosa cell proliferation and aromatase activity by amplifying cAMPmediated postreceptor signaling [19, [50] [51] [52] [53] [54] [55] [56] [57] . In our model, estrogen production was also decreased in both treatments in a dose dependent manner but was (at least in the bicalutamide treatment) not ascribed to reduced aromatase activity. Recently, a role for androgen-activated AR has been demonstrated in increasing FSH receptor expression [54, [58] [59] [60] and in augmenting mitogenic effects of oocyte-secreted factors and growth differentiation factor 9 [61] on granulosa cells. Also, the intraovarian insulin-like growth factor paracrine/autocrine system, which has an essential role in regulating ovarian follicular development, was shown to be responsive to androgens [61] [62] [63] . Hence, the primary role of AR in vivo seems to be amplification of gonadotroph signaling. Previously, it was demonstrated that a minimal dose of 10 mIU/ml of FSH is necessary in this mouse model to ensure normal follicular growth and development [22] . Thus, it can be hypothesized that by inhibiting AR-mediated actions in vitro this carefully fine-tuned minimal dose of 10 mIU/ml of FSH is no longer sufficient to sustain normal follicular growth and development. Whether AR can upregulate FSH receptor expression in this model needs further investigation.
Surprisingly, growth-retarded follicles were able to catch up and developed into normal healthy-looking preovulatory phenotypes by Day 12 of culture. In concert with this morphological observation of a growth spurt, there was a significantly elevated proportional increase in inhibin B production between Day 8 and Day 12 of culture, and this finding excluded nonspecific toxicity of this high concentration of antagonists. A plausible explanation could be decreasing AR expression during antral growth that results in attenuation of the antagonistic actions of antagonists. In contrast, downregulation of AR with progression of growth is thought to be a means of avoiding inappropriately high cAMP levels [19] and, hence, premature arrest of proliferation of granulosa cells that would lead to follicle atresia [19, 41] . Thus, if antagonists were capable of binding AR during antral follicular development in vitro, this would contribute only to developmentally regulated downregulation of AR, and no adverse effects of OHF on follicular growth/differentiation or health would be expected.
Although oocytes exposed to 50 lM of either antagonist failed to reinitiate meiosis in response to hCG, they were of normal size (data not shown) and viable because mucification of the COC, an oocyte-dependent process [64, 65] , was triggered. Because we and others [32, 33] found AR expressed within the oocyte, this antagonistic effect of OHF on oocyte maturation might be direct, implying that androgens would have beneficial effects on oocyte maturation. Under some experimental conditions, steroids have been reported to modulate meiosis [66, 67] , although some controversy exists. A recent study [32] in mouse oocytes showed increased meiotic maturation via a nongenomic AR-mediated mitogen-activated protein kinase and cyclin-dependent kinase 1 pathway. A 40-fold excess of OHF over testosterone resulted in partial meiotic arrest. In contrast, in rat follicle-enclosed oocytes flutamide also caused a concentration-dependent inhibition of LHinduced GVBD, but this was not receptor mediated [68] . The addition of DHT in the present study could partially overcome meiotic arrest in bicalutamide-treated oocytes (but not in OHFtreated oocytes) and suggests at least a partially AR-mediated effect.
In conclusion, in this study we demonstrated that (as in vivo) AR expression in this follicle culture model is developmentally regulated, providing a physiological model to test EDs with antiandrogenic properties. In contrast to in vitro systems that use genetically engineered cells, the genes under study in this biologically relevant model are at the appropriate place in the chromosome and possess complete promoters, and their translation is under the natural control mechanisms of the cell, which allows measurement of a biological response. Antagonizing AR-mediated actions in this model resulted in affected follicular growth and development, arrested oocyte meiotic maturation, and altered steroid production, confirming observations in other in vitro test systems. In this sense, the mouse follicle bioassay proves to be sensitive and have good positive predictive potential. Based on the present findings, this multiparametric bioassay can be considered a suitable tool to study AR-mediated actions in more depth and to gain insights into the potential disruptive actions of antiandrogens on folliculogenesis, steroidogenesis, and oocyte competence.
